Market growth, key challenges and scaling up: An interview with Scott Merz, Business Development Manager at Asahi Kasei Bioprocess America, Inc.
Oligonucleotide manufacturing success relies on a seamless flow from start to finish, so how can equipment be optimized for this?
TIDES TV sat down for a chat with Scott Merz, Business Development Manager at Asahi Kasei Bioprocess America (AKBA).
Merz discussed the recent oligo manufacturing market growth, key considerations and pitfalls in manufacturing processes, and common challenges in scaling up equipment.
Click the image to watch the full interview.